UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033442
Receipt number R000038139
Scientific Title A study to investigate Postprandial blood glucose level increase suppressing effect of study food ingestion
Date of disclosure of the study information 2018/07/20
Last modified on 2018/07/19 14:15:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to investigate Postprandial blood glucose level increase suppressing effect of study food ingestion

Acronym

A study to investigate Postprandial blood glucose level increase suppressing effect of study food ingestion

Scientific Title

A study to investigate Postprandial blood glucose level increase suppressing effect of study food ingestion

Scientific Title:Acronym

A study to investigate Postprandial blood glucose level increase suppressing effect of study food ingestion

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to assess the
effect of single ingestion of tea polyphenols-containing beverage on postprandial blood glucose level by performing the comparison suing cross-over study

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Postprandial blood glucose level (AUC,C-Max)

Key secondary outcomes

Awareness questionnaire


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of study food substance (Once)
Ingestion of control food substance (Once)

Interventions/Control_2

Ingestion of control food substance (Once)
Ingestion of study food substance (Once)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Subjects who is healthy adults of both sexes above 20 years old- under 65 years old
2)Subjects with fasting blood glucose level under 125mg/dL, and under 199mg/dL after food load at the point of screening
3)Subjects who give consent in writing with full understanding

Key exclusion criteria

1)Subjects who has difficulties to participate this study due to hepatic, kidney, cardiac disorders, lung disorder, digestive system disorder, blood disorder, endocrine disorder, metabolic defect and other serious disorders.
2)Subjects who suffer from diseases/ disorders with continuous medical treatment or with medical history of severe diseases/ disorders needed medical treatment
3)Subjects who suffer from diseases/ disorders that affects the study and are receiving medical treatment from medical institution or have surgical history of digestive system ( except appendectomy)
4)Subjects with history of sensitivity to the ingredients of test food
5)Pregnant, lactating women or willing to be pregnancy during the study
6)Subjects who had participated in other clinical trials including drug and food within 1 month.
7)Any candidates considered to be unsuitable for enrollment in the opinion of the principal investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Wei Na

Organization

Tasly Japan Co.,Ltd.

Division name

Planning Department

Zip code


Address

3-5-7 ariake,Kouto-ku ,Tokyo,Japan

TEL

03-3529-0101

Email

nai@tasly.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigeru Imai

Organization

CROee.INC

Division name

Evidence Division

Zip code


Address

2F YS Build. 1-13-23 Minamiikebukuro Toshima-ku, Tokyo, Japan

TEL

03-5953-2108

Homepage URL


Email

imai@croee.com


Sponsor or person

Institute

CROee.INC

Institute

Department

Personal name



Funding Source

Organization

Tasly Japan Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京センタークリニック(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 07 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 08 Month 08 Day

Last follow-up date

2018 Year 08 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 19 Day

Last modified on

2018 Year 07 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038139


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name